Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview

被引:88
|
作者
Banerjee, Suvankar [1 ]
Adhikari, Nilanjan [1 ,2 ]
Amin, Sk Abdul [1 ]
Jha, Tarun [1 ]
机构
[1] Jadavpur Univ, Dept Pharmaceut Technol, Nat Sci Lab, Div Med & Pharmaceut Chem, POB 17020, Kolkata 700032, W Bengal, India
[2] ADAMAS Univ, Sch Pharmaceut Technol, Barasat Barrackpore Rd,PO Jagannathpur, Kolkata 700126, W Bengal, India
关键词
Histone deacetylase; HDAC8; Cancer; inhibitor; Structure-activity relationship (SAR); Quantitative structure-activity relationship (QSAR); DE-LANGE-SYNDROME; SUBEROYLANILIDE HYDROXAMIC ACID; ZINC-BINDING GROUP; BIOLOGICAL EVALUATION; PHASE-I; MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURE; ACTIVITY ASSAY; UP-REGULATION; DESIGN;
D O I
10.1016/j.ejmech.2018.12.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The histone deacetylases (HDACs) enzymes provided crucial role in transcriptional regulation of cells through deacetylation of nuclear histone proteins. Discoveries related to the HDAC8 enzyme activity signified the importance of HDAC8 isoform in cell proliferation, tumorigenesis, cancer, neuronal disorders, parasitic/viral infections and other epigenetic regulations. The pan-HDAC inhibitors can confront these conditions but have chances to affect epigenetic functions of other HDAC isoforms. Designing of selective HDAC8 inhibitors is a key feature to combat the pathophysiological and diseased conditions involving the HDAC8 activity. This review is concerned about the structural and positional aspects of HDAC8 in the HDAC family. It also covers the contributions of HDAC8 in the pathophysiological conditions, a preliminary discussion about the recent scenario of HDAC8 inhibitors. This review might help to deliver the structural, functional and computational information in order to identify and design potent and selective HDAC8 inhibitors for target specific treatment of diseases involving HDAC8 enzymatic activity. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:214 / 240
页数:27
相关论文
共 50 条
  • [31] Selective targeting deacetylase 3 (HDAC3) and HDAC8 by PROTACs
    Xiao, Yufeng
    Hale, Seth
    Awasthee, Nikee
    Zhang, Xuan
    Liu, Yi
    Huo, Zhiguang
    Lyu, Dongwen
    Wang, Lei
    Zhang, Weizhou
    Mosteiro, Megan
    Liao, Daiqing
    Zheng, Guangrong
    CANCER RESEARCH, 2023, 83 (07)
  • [32] Elevated expression of histone deacetylase HDAC8 suppresses arginine-proline metabolism in necrotizing enterocolitis
    Guo, Ting
    Hu, Shaohua
    Xu, Weijue
    Zhou, Jin
    Chen, Feng
    Gao, Tingting
    Qu, Wenqian
    Chen, Faling
    Lv, Zhibao
    Lu, Li
    ISCIENCE, 2023, 26 (06)
  • [33] Histone deacetylase HDAC8 associates with smooth muscle α-actin and is essential for smooth muscle cell contractility
    Waltregny, D
    Glénisson, W
    Tran, SL
    North, BJ
    Verdin, E
    Colige, A
    Castronovo, V
    FASEB JOURNAL, 2005, 19 (03): : 966 - +
  • [34] Dynamic Structure-Based Pharmacophore Model Development: A New and Effective Addition in the Histone Deacetylase 8 (HDAC8) Inhibitor Discovery
    Thangapandian, Sundarapandian
    John, Shalini
    Lee, Yuno
    Kim, Songmi
    Lee, Keun Woo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2011, 12 (12) : 9440 - 9462
  • [35] Molecular Basis for the Antiparasitic Activity of a Mercaptoacetamide Derivative That Inhibits Histone Deacetylase 8 (HDAC8) from the Human Pathogen Schistosoma mansoni
    Stolfa, Diana A.
    Marek, Martin
    Lancelot, Julien
    Hauser, Alexander-Thomas
    Walter, Alexandra
    Leproult, Emeline
    Melesina, Jelena
    Rumpf, Tobias
    Wurtz, Jean-Marie
    Cavarelli, Jean
    Sippi, Wolfgang
    Pierce, Raymond J.
    Romier, Christophe
    Jung, Manfred
    JOURNAL OF MOLECULAR BIOLOGY, 2014, 426 (20) : 3442 - 3453
  • [36] Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity
    Darwish, Salma
    Ghazy, Ehab
    Heimburg, Tino
    Herp, Daniel
    Zeyen, Patrik
    Salem-Altintas, Rabia
    Ridinger, Johannes
    Robaa, Dina
    Schmidtkunz, Karin
    Erdmann, Frank
    Schmidt, Matthias
    Romier, Christophe
    Jung, Manfred
    Oehme, Ina
    Sippl, Wolfgang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
  • [37] A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
    Balasubramanian, S.
    Ramos, J.
    Luo, W.
    Sirisawad, M.
    Verner, E.
    Buggy, J. J.
    LEUKEMIA, 2008, 22 (05) : 1026 - 1034
  • [38] A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
    S Balasubramanian
    J Ramos
    W Luo
    M Sirisawad
    E Verner
    J J Buggy
    Leukemia, 2008, 22 : 1026 - 1034
  • [39] THERAPEUTIC EFFECTS OF HISTONE DEACETYLASE ENZYME 8 INHIBITORS (HDAC8I) IN A MURINE ASTHMA MODEL
    Ren, Yuan
    Su, Xinming
    RESPIROLOGY, 2017, 22 : 57 - 58
  • [40] Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma
    Tian, Yuan
    Wong, Vincent W. S.
    Wong, Grace L. H.
    Yang, Weiqin
    Sun, Hanyong
    Shen, Jiayun
    Tong, Joanna H. M.
    Go, Minnie Y. Y.
    Cheung, Yue S.
    Lai, Paul B. S.
    Zhou, Mingyan
    Xu, Gang
    Huang, Tim H. M.
    Yu, Jun
    To, Ka F.
    Cheng, Alfred S. L.
    Chan, Henry L. Y.
    CANCER RESEARCH, 2015, 75 (22) : 4803 - 4816